PCOS and Thyroid: Why These Two Conditions So Often Go Together

Introduction

If you have PCOS and you have also been told you have a thyroid condition - or if you suspect your thyroid may be involved but have been told your results are normal - you are far from alone.

Thyroid dysfunction, particularly Hashimoto's thyroiditis and hypothyroidism, is significantly more prevalent in women with PCOS than in the general population. Research puts the overlap at two to three times the background rate - and this is not coincidence.¹

The two conditions share overlapping mechanisms: autoimmune terrain, chronic inflammation, insulin resistance, and hormonal dysregulation that compound each other in ways that make both harder to manage when only one is being addressed.

What is particularly frustrating is that these conditions are almost always managed in isolation. Your endocrinologist or GP treats the thyroid. Someone else manages the PCOS. And nobody steps back to look at the full metabolic picture and explain why you are still symptomatic despite treatment for both.

This article does that.

Why PCOS and Thyroid Conditions Occur Together

The co-occurrence of PCOS and thyroid dysfunction is not coincidental - there are specific biological reasons why the two conditions share common ground.

Shared Autoimmune Terrain

Hashimoto's thyroiditis - the most common cause of hypothyroidism in developed countries - is an autoimmune condition in which the immune system produces antibodies against thyroid tissue, progressively impairing thyroid function over time.

Women with PCOS have measurably elevated rates of autoimmune activity generally, and Hashimoto's specifically. The mechanism is not fully resolved, but chronic low-grade inflammation - a defining feature of PCOS - is a primary driver of autoimmune dysregulation. When the immune system is in a state of chronic inflammatory activation, the threshold for autoimmune reactivity is lowered.²

This is the same inflammatory environment detailed in PCOS and Inflammation - the same cytokines, the same NF-κB activation, the same oxidative stress. In women with PCOS, this environment creates a heightened susceptibility to autoimmune conditions broadly, and Hashimoto's in particular.

Insulin Resistance Impairs Thyroid Function

Insulin resistance does not only affect glucose metabolism. It has direct consequences for thyroid hormone production and conversion that are clinically significant and almost never discussed in standard thyroid management.

Chronically elevated insulin - the compensatory response to insulin resistance - stimulates TSH (thyroid stimulating hormone) secretion and promotes thyroid gland enlargement. It also impairs the conversion of T4 (the inactive thyroid hormone) to T3 (the active form) in peripheral tissues.³

This matters because most standard thyroid treatment focuses on T4 replacement (levothyroxine) without addressing whether T4 is being adequately converted to T3 in the body. In a woman with PCOS and significant insulin resistance, this conversion may be impaired - meaning thyroid hormone levels look adequate on paper while the active hormone available to cells is insufficient for normal metabolic function.

This is one of the most common reasons women with both PCOS and thyroid dysfunction continue to feel symptomatic despite being on thyroid medication and having TSH within the reference range.

Shared Hormonal Dysregulation

Both PCOS and hypothyroidism affect sex hormone-binding globulin (SHBG). Hypothyroidism reduces SHBG production by the liver - the same effect as chronically elevated insulin in PCOS. Lower SHBG means more free testosterone circulating in the body, amplifying the androgenic symptoms of PCOS.

Hypothyroidism also impairs the liver's clearance of oestrogen, contributing to relative oestrogen excess - which further disrupts the LH/FSH balance already dysregulated in PCOS.

The hormonal consequence of having both conditions simultaneously is a compounding of androgen excess and oestrogen dysregulation that goes beyond what either condition produces independently.

The TSH Debate: Why "Normal" May Not Mean Optimal

This is the most clinically important and most contentious aspect of thyroid management in women with PCOS - and it is worth addressing directly.

The standard TSH reference range used in most laboratories is approximate. A result within the range is typically reported as normal, and thyroid dysfunction is frequently ruled out on this basis alone.

The problem is that the range was derived from population studies that included individuals with subclinical thyroid disease - meaning the "normal" range reflects what is statistically common, not what is optimal for metabolic health and symptom resolution.

A growing body of clinical evidence and practitioner consensus suggests that for optimal thyroid function - and particularly for women with PCOS, insulin resistance, or autoimmune thyroid disease - a more functionally optimal TSH range is more appropriate.⁴

Women whose TSH is at the higher end of the standard reference range - may be experiencing clinically significant thyroid underfunction without meeting the threshold for formal hypothyroid diagnosis. Symptoms including fatigue, weight resistance, cold intolerance, cognitive fog, constipation, hair thinning, and low mood can all be present at TSH levels that are technically "normal."

This becomes particularly consequential in PCOS, where these symptoms overlap significantly with PCOS-related metabolic dysfunction - making it difficult to identify the thyroid contribution without a more thorough investigation.

If you have PCOS and ongoing symptoms despite dietary and lifestyle management - particularly persistent fatigue, unexplained weight resistance, cognitive fog, and hair thinning - request a full thyroid panel from your GP, not just TSH. A complete panel includes: TSH, free T4, free T3, reverse T3, thyroid peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (TgAb).

Symptoms: Where PCOS and Thyroid Overlap

One of the significant clinical challenges in managing both conditions is that their symptom profiles overlap substantially - making it difficult to identify which condition is driving which symptom without thorough investigation.

Symptoms common to both PCOS and hypothyroidism include:

• Fatigue and low energy - one of the most universal complaints in both conditions, with different but compounding mechanisms
• Weight gain and difficulty losing weight - both conditions independently impair metabolic rate and promote fat storage; together, the effect is significantly amplified
• Hair thinning and hair loss - as covered in PCOS and Hair Loss, androgenic alopecia in PCOS is compounded by the telogen effluvium and hair shaft changes of hypothyroidism
• Cognitive fog and poor concentration - both insulin resistance and low T3 impair neurological function and cognitive clarity
• Mood changes and depression - thyroid hormone directly affects serotonin and dopamine metabolism; hypothyroidism is a significant driver of depression independent of PCOS
• Irregular cycles - hypothyroidism independently disrupts the HPO axis and cycle regularity, compounding the anovulatory patterns of PCOS
• Constipation and sluggish digestion - hypothyroidism slows gut motility significantly, adding to the gut dysbiosis picture relevant to PCOS
• Cold intolerance - more specific to hypothyroidism, but present in women with PCOS who have significant metabolic dysfunction

The overlap means that women with both conditions frequently attribute all their symptoms to one diagnosis - usually the one that was identified first - while the second remains inadequately investigated or managed.

How Hypothyroidism Worsens Insulin Resistance

The relationship between thyroid function and insulin sensitivity is direct and clinically significant - and it creates a feedback loop that is important to understand.

Thyroid hormones - particularly T3 - are essential regulators of cellular metabolism. T3 directly influences GLUT4 transporter activity (the mechanism by which cells absorb glucose), mitochondrial function, and the rate at which cells utilise glucose and fat for energy.

When T3 is insufficient - either because thyroid hormone production is reduced or because T4-to-T3 conversion is impaired - cellular metabolic rate slows. Cells become less efficient at absorbing and utilising glucose, insulin receptor sensitivity decreases, and insulin resistance worsens.⁵

This creates a direct bidirectional loop with PCOS:

• PCOS-driven insulin resistance impairs T4-to-T3 conversion
• Impaired T3 availability worsens insulin resistance
• Worsened insulin resistance drives more androgen production
• Elevated androgens amplify the inflammatory environment
• Chronic inflammation further suppresses thyroid function

For women with both conditions, this loop can explain why their insulin resistance appears disproportionately severe relative to their dietary and lifestyle picture - and why it proves resistant to dietary intervention alone without thyroid optimisation alongside it.

For the foundational explanation of insulin resistance in PCOS: PCOS and Insulin Resistance and Signs of Silent Insulin Resistance in Women

Hashimoto's, Gluten, and the Autoimmune Connection

This is an area where the evidence is nuanced and the wellness noise is loud - so it is worth addressing carefully.

There is a well-documented association between Hashimoto's thyroiditis and coeliac disease - a serious autoimmune condition involving immune reactivity to gluten. Women with Hashimoto's have a significantly higher prevalence of coeliac disease than the general population, and the autoimmune mechanisms overlap.⁶

The clinical implication is straightforward: women with PCOS and confirmed Hashimoto's should be screened for coeliac disease - not assumed to have it, but specifically tested.

The question of non-coeliac gluten sensitivity in Hashimoto's - and by extension in PCOS with autoimmune features - is less settled. Some clinical practitioners find that a gluten-elimination trial produces meaningful improvements in autoimmune markers and symptom burden in women with Hashimoto's even without confirmed coeliac disease. The research is not yet conclusive, but the mechanistic basis - gluten's potential to increase intestinal permeability and stimulate immune reactivity - is plausible in the context of the leaky gut pathway detailed in PCOS and Gut Health.

This is a decision best made in consultation with a clinician who can interpret your specific antibody levels, symptom picture, and history - rather than as a blanket dietary rule applied without context.

Iodine, Selenium, and Thyroid Function

Two nutrients have specific and well-evidenced roles in thyroid function that are worth understanding in the context of PCOS.

Selenium is required for the enzyme that converts T4 to active T3 (iodothyronine deiodinase), and for the antioxidant enzymes that protect thyroid tissue from the significant oxidative stress generated during thyroid hormone synthesis. Selenium deficiency impairs both T4-to-T3 conversion and the thyroid's ability to protect itself from autoimmune damage.

Food sources of selenium: Brazil nuts (2–3 per day provides approximately 200mcg), tuna, sardines, eggs, and sunflower seeds.

Iodine is essential for thyroid hormone synthesis - without adequate iodine, the thyroid cannot produce T4 or T3 in sufficient quantities. Iodine deficiency is a global cause of hypothyroidism.

However, the relationship between iodine and autoimmune thyroid disease is complex. Excessive iodine intake in women with existing Hashimoto's can paradoxically worsen autoimmune activity - triggering thyroid peroxidase enzyme dysfunction and increasing oxidative damage to thyroid tissue. The therapeutic window is narrow, and supplementation with iodine in the context of Hashimoto's requires clinical guidance rather than self-prescription.

Food-based iodine from seaweed, seafood, eggs, and dairy is appropriate. High-dose iodine supplementation without established deficiency and clinical oversight is not recommended in the context of autoimmune thyroid disease.

The Role of Cortisol and Sleep

Two factors that are already well-established as drivers of PCOS metabolic dysfunction have specific additional consequences for thyroid function.

Chronic cortisol elevation directly suppresses TSH secretion, impairs T4-to-T3 conversion, and promotes conversion to reverse T3 (rT3) - an inactive form of T3 that competes with active T3 for receptor binding. Women with elevated cortisol and poorly regulated HPA axis function may therefore have low active T3 availability even when their TSH and T4 appear normal - a pattern sometimes referred to as functional hypothyroidism.

This is one more mechanism by which the cortisol dysregulation of PCOS compounds thyroid dysfunction - and one more reason why addressing HPA axis regulation is a systemic metabolic priority rather than a soft wellness recommendation. Full detail: Cortisol and PCOS

Poor sleep independently elevates reverse T3 and reduces active T3 conversion. Adequate sleep is therefore not just a metabolic and cortisol intervention - it is directly protective of thyroid hormone availability. PCOS and Sleep

What to Ask Your Doctor: A Practical Testing Guide

Given how frequently thyroid dysfunction is incompletely investigated in women with PCOS, knowing specifically what to ask for is practically useful.

Full thyroid panel - not just TSH:

• TSH (thyroid stimulating hormone)
• Free T4 (unbound, active thyroxine)
• Free T3 (unbound, active triiodothyronine)
• Reverse T3 (rT3) - if conversion impairment is suspected
• Thyroid peroxidase antibodies (TPO-Ab)
• Thyroglobulin antibodies (TgAb)

Thyroid ultrasound - if antibodies are elevated or thyroid is palpably enlarged, an ultrasound provides structural information about the gland that blood tests alone cannot. Hashimoto's produces characteristic echographic changes that confirm the diagnosis and help track progression.

Coeliac screen - if Hashimoto's is confirmed: anti-tissue transglutaminase IgA, anti-endomysial antibodies, total IgA.

Metabolic markers - fasting insulin, fasting glucose, lipid panel, and vitamin D, given the compounding effects of insulin resistance and vitamin D deficiency on both conditions.

TIP If your GP is willing to test only TSH, you can request the additional markers by explaining that you have a confirmed PCOS diagnosis and are concerned about the elevated co-occurrence of autoimmune thyroid disease in this population. Many GPs will accommodate a more thorough panel with that clinical context provided. If testing is declined and your symptoms are significant, a referral to an endocrinologist or a consultation with a functional medicine practitioner who routinely runs comprehensive thyroid panels is a reasonable next step.

What to Do With the Results: A Clinical Framework

If thyroid antibodies are elevated but TSH is within the standard reference range, you have early Hashimoto's. This is an important finding even without a formal hypothyroid diagnosis - it indicates active autoimmune activity directed at thyroid tissue and warrants:

• Anti-inflammatory dietary intervention targeting the shared inflammatory terrain of PCOS and autoimmune disease
• Selenium supplementation as per the evidence discussed above
• Monitoring thyroid function every six to twelve months - antibody-positive individuals progress to clinical hypothyroidism at a meaningful rate and warrant regular reassessment
• Coeliac screening
• Investigation of vitamin D status and correction of deficiency

If TSH is at the upper end of the reference range alongside symptoms and positive antibodies, this is a clinical conversation worth having directly with your GP or endocrinologist - specifically framing it around functional TSH optimisation rather than simply whether you meet the diagnostic threshold for treatment.

If free T3 is low or reverse T3 is elevated despite apparently adequate TSH and T4, the T4-to-T3 conversion impairment pathway is likely operating. This is where the intersection of insulin resistance, cortisol dysregulation, and thyroid function becomes most clinically relevant - and where addressing the metabolic drivers of PCOS most directly benefits thyroid hormone availability.

The Bottom Line

PCOS and thyroid dysfunction - particularly Hashimoto's - are not two separate conditions that happen to co-occur. They share inflammatory terrain, compound each other's effects on insulin resistance and hormonal balance, and produce a symptom burden that is greater than the sum of its parts.

The most important practical takeaway is simple: if you have PCOS and ongoing symptoms that are not fully explained by your PCOS management - persistent fatigue, weight resistance, cognitive fog, hair loss, mood changes - a thorough thyroid investigation is warranted. Not just TSH. A full panel including antibodies.

And if you have both conditions, the most effective approach treats them within the same metabolic framework - addressing the shared inflammatory and insulin-resistant terrain that drives both, rather than managing each in a separate clinical silo.

The conditions share a root. The approach should reflect that.

Managing the Overlap Between PCOS and Thyroid Conditions?

In clinic, I assess the full metabolic picture - including the inflammatory, autoimmune, and hormonal interactions between PCOS and thyroid dysfunction that are so often missed in standard care.

Our Metabolic Balance® programme uses your individual blood chemistry to design a personalised nutrition protocol that addresses the shared metabolic root of both conditions - reducing inflammatory load, improving insulin sensitivity, and supporting thyroid hormone conversion through targeted nutritional intervention.

For women managing both PCOS and thyroid dysfunction, a whole-system metabolic approach is not optional. It is the most clinically complete path forward.

👉 Book a Health Strategy Session

In-clinic and remote consultations available.

Free Resource - Start Here

The 7-Day Metabolic Reset is a free, structured guide for women with PCOS and insulin resistance - covering blood sugar stabilisation, anti-inflammatory nutrition, and practical daily strategies in a clear seven-day framework.

👉 Download the 7-Day Metabolic Reset

References

1. Janssen OE, et al. (2004). High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. European Journal of Endocrinology, 150(3), 363–369.
2. Sategna-Guidetti C, et al. (1998). Autoimmune thyroid diseases and coeliac disease. European Journal of Gastroenterology & Hepatology, 10(11), 927–931.
3. Brenta G. (2011). Why can insulin resistance be a natural consequence of thyroid dysfunction? Journal of Thyroid Research, 2011, 152850.
4. Wartofsky L & Dickey RA. (2005). The evidence for a narrower thyrotropin reference range is compelling. Journal of Clinical Endocrinology & Metabolism, 90(9), 5483–5488.
5. Tuzcu A, et al. (2007). Impact of dehydroepiandrosterone sulphate on insulin sensitivity in patients with hypothyroidism. Annals of Medical Sciences, 16, 17–21.
6. Sategna-Guidetti C, et al. (2001). The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Alimentary Pharmacology & Therapeutics, 14(1), 35–43.
7. Gärtner R, et al. (2002). Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology & Metabolism, 87(4), 1687–1691.